IP Library Granted Patent US 9,101,515
Granted Patent B2
US 9,101,515 · App. 13/132,176 · Granted Aug 11, 2015

Absorbent medical body, in particular for removing wound fluids from human and/or animal body cavities, and method for its production

Inventors: Erich Odermatt (Schaffhausen, CH); Ingo Berndt (Tuttlingen, DE); Silke König (Rottweil, DE)
Assignee: Aesculap AG
A61F13/20A61F13/15211A61F13/36A61M27/00A61F2013/0054A61F2013/00536A61F2013/00642A61F2013/15235
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,101,515
App. No.
13/132,176
Granted
Aug 11, 2015
Kind
B2
Abstract

An absorbent medical body for removing wound fluids from human and/or animal body cavities includes a material which holds the absorbent body together in a compressed form and can be removed upon contact with a biocompatible liquid.

Claims (29)

1. An absorbent medical body that removes wound fluids from human and/or animal body cavities comprising a material which holds the absorbent body together in a compressed form and can be removed upon contact with a biocompatible liquid, wherein the material is a three-dimensional network interpenetrating the absorbent body and is formed as a partial coating on and/or inside the absorbent body and openings in the absorbent body are partially covered by the material.

2. The absorbent medical body according to claim 1 , wherein the material dissolves upon contact with a biocompatible liquid.

3. The absorbent medical body according to claim 1 , wherein the material is formed as a partial coating, on and/or inside the absorbent body.

4. The absorbent medical body according to claim 1 , wherein the openings are pore webs partially encapsulated by the material.

5. The absorbent medical body according to claim 1 , wherein the openings are pores partially covered with the material.

6. The absorbent medical body according to claim 1 , wherein a proportion of the material is between 0.3 and 30 wt. % expressed in terms of the total weight of the absorbent body.

7. The absorbent medical body according to claim 1 , wherein the material is in a freeze-dried form.

8. The absorbent medical body according to claim 1 , wherein the material is selected from the group consisting of proteins, polysaccharides, cellulose derivatives and/or mucopolysaccharides, and polymers, collagen, elastin, gelatine, dextran, methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, dextran, hyaluronic acid, chondroitin sulfate, alginic acid, chitosan, heparin, polyvinyl alcohol, polyethylene glycol and mixtures thereof.

9. The absorbent medical body according to claim 1 , wherein the material is a low molecular weight compound and/or a salt.

10. The absorbent medical body according to claim 1 , wherein the absorbent body in the compressed form has a volume reduced by from 10 to 90% expressed in terms of the volume of the absorbent body without the material.

11. The absorbent medical body according to claim 1 , wherein the absorbent body in the compressed form is formed so that it is flexible.

12. The absorbent medical body according to claim 1 , wherein the absorbent body in the compressed form is formed so that it is elastic.

13. The absorbent medical body according to claim 1 , wherein the absorbent body is a sponge or foam body.

14. The absorbent medical body according to claim 1 , wherein the absorbent body is formed from a non-absorbable polymer selected from the group consisting of polypropylene, polyethylene, polyethylene terephthalate, polyurethane, silicone, polyvinyl alcohol, derivatives thereof, copolymers thereof and mixtures thereof.

15. The absorbent medical body according to claim 1 , wherein the absorbent body is formed from an absorbable polymer selected from the group consisting of polylactide, polyglycolide, poly-ε-caprolactone, trimethylene carbonate, poly-para-dioxanone, hydroxybutyric acid, copolymers thereof and mixtures thereof.

16. The absorbent medical body according to claim 1 , wherein the absorbent body is formed from a co- or terpolymer, comprising at least one monomer selected from the group consisting of lactide, glycolide, ε-caprolactone, trimethylene carbonate, para-dioxanone and hydroxybutyric acid.

17. The absorbent medical body according to claim 1 , wherein the absorbent body comprises pores with a diameter of between 100 and 1500 μm.

18. The absorbent medical body according to claim 1 , wherein the absorbent body comprises a drainage tube and, optionally, a flushing tube.

19. The absorbent medical body according to claim 1 , wherein the absorbent body is a drainage article for discharging pathological fluid accumulations from human and/or animal body cavities.

20. A method for producing an absorbent medical body according to claim 1 , comprising:

a) compressing an absorbent body into a compressed form,

b) wetting or soaking the absorbent body provided in the compressed form with a solution or suspension comprising a material which is removable upon contact with a biocompatible liquid and a solvent or solvent mixture,

c) drying the compressed and wetted or soaked absorbent body by removing the solvent or solvent mixture.

21. The method according to claim 20 , wherein the absorbent body is compressed by insertion into a hollow body.

22. The method according to claim 20 , wherein, to wet or soak the absorbent body, the absorbent body is immersed in the compressed form into the solution or suspension.

23. The method according to claim 20 , wherein, to wet or soak the absorbent body, the absorbent body is sprayed in the compressed form with the solution or suspension.

24. The method according to claim 20 , wherein a solution or suspension has a proportion of the material between 0.3 and 30 wt. %, expressed in terms of the total weight of the solution or suspension.

25. The method according to claim 20 , wherein, during or after the wetting or soaking of the absorbent body, a negative pressure or vacuum is generated so that the solution or suspension penetrates fully through the absorbent body.

26. The method according to claim 20 , wherein the absorbent body is dried by lyophilization.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2024
From: AESCULAP AG
To: BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED
Reel/Frame 067699/0410 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2011
From: ODERMATT, ERICH; BERNDT, INGO; KONIG, SILKE
To: AESCULAP AG
Reel/Frame 026512/0415 →
Priority Claims (1)
DE 10 2008 061 535 · Dec 3, 2008 · national
Continuity (1)
Related Publication 20110270205A1 · Nov 3, 2011